3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Suspended
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Conditions
Thrombosis
1
Neoplasms
1
Metabolic Diseases
1
Malignant Female Reproductive System Neoplasm
1
Hematologic Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Catheter-Related Infections
1
Bacteremia
1
Anemia, Aplastic
1
Interventions
Heparin
1
Enoxaparin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Malignant Female Reproductive System Neoplasm
×
Heparin
×
Clear all
NCT01356329
2016-05-13
Lovenox
National Guard Health Affairs
Phase 3
Suspended
150 enrolled